Co-Authors
This is a "connection" page, showing publications co-authored by Simon Tiberi and Gina Gualano.
Connection Strength
0.558
-
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. Eur Respir J. 2021 11; 58(5).
Score: 0.061
-
TB and COVID-19 co-infection: rationale and aims of a global study. Int J Tuberc Lung Dis. 2021 01 01; 25(1):78-80.
Score: 0.058
-
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. Emerg Infect Dis. 2020 11; 26(11):2709-2712.
Score: 0.056
-
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020 07; 56(1).
Score: 0.056
-
Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study. Open Forum Infect Dis. 2019 Jan; 6(1):ofy337.
Score: 0.050
-
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries. Am J Respir Crit Care Med. 2018 08 01; 198(3):379-386.
Score: 0.049
-
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update. Eur Respir J. 2018 05; 51(5).
Score: 0.048
-
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure. Am J Respir Crit Care Med. 2017 11 01; 196(9):1222-1224.
Score: 0.046
-
Treatment outcomes of MDR-TB and HIV co-infection in Europe. Eur Respir J. 2017 06; 49(6).
Score: 0.045
-
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J. 2017 05; 49(5).
Score: 0.045
-
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. Eur Respir J. 2017 03; 49(3).
Score: 0.044